Rp loclzj tum whbdy 2+d img
CPT 78804 covers whole body nuclear medicine imaging to locate tumors in two or more areas of the body using radioactive tracers. This specialized scan helps doctors identify cancer spread or tumor locations throughout multiple body regions.
This calculator gives a typical-case estimate using standard Medicare modifier rules. Actual payment depends on payer policies, documentation, code-specific CMS status indicators, and locality. Verify before billing.
RVU breakdown
Conversion factor: 32.3465 · Source: CMS MPFS RVU25A · Confidence: High
NCCI bundling edits
Loading bundling edits…
Billing tips
Document all anatomical areas imaged (minimum 2 required for 78804) in the radiology report with specific tumor localization findings
Impact: Prevents downcoding to single-area codes (78803) which reimburse approximately $150-200 less; ensures full $552.80 reimbursement
Verify radiotracer type and dose administration are documented separately with appropriate diagnostic radiopharmaceutical code (A9500-A9699 series)
Impact: Radiopharmaceutical drugs billed separately can add $800-3000 depending on agent used (e.g., Octreoscan, FDG); failure to bill separately loses significant revenue
Distinguish 78804 from PET scans (78811-78816) in documentation; do not use for FDG-PET whole body imaging
Impact: Using incorrect code family can result in payment differences of $500-1500; PET codes have different coverage criteria and higher reimbursement
Confirm medical necessity documentation includes specific tumor type, staging indication, or treatment response assessment
Impact: LCD and NCD policies require specific indications; missing documentation leads to 15-25% denial rate for this code
Bill on same date as radiotracer injection only; do not split imaging date from injection date for reimbursement purposes
Impact: Date discrepancies trigger automatic denials; ensure both injection and imaging components share same service date even if delayed imaging protocol used
For split billing arrangements, coordinate 26/TC modifier usage with referring facility to prevent duplicate billing
Impact: Duplicate submissions without proper modifiers result in 100% denial of second claim and potential fraud investigation; coordination ensures both parties receive appropriate portion
Real billers contribute denial patterns and appeal strategies for this code. Once 5+ reports come in, you’ll see live aggregated data here — the only place this exists, free.
Get the free Revenue Protection Toolkit — the denial triggers, modifier pitfalls, and bundling conflicts that quietly cost you reimbursement. Instant download.
Help build the field knowledge
MedPayIQ gets smarter as billers contribute. If you've had this code denied, share what happened so others learn from it. Anonymous, no patient info.